Medical cannabis and cannabinoids
Med Cannabis Cannabinoids
· ISSN (e) 2504-3889
· 7 papers in corpus
other
2025
BACKGROUND: At least 60% of individuals with anxiety disorders report sleep disturbances, which might be explained by shared physiological mechanisms, including cortisol dysregulation and executive function skills disruption. The scientific…
other
2024
[This corrects the article DOI: 10.1159/000534044.].
other
2024
INTRODUCTION: Subjective improvement in gastrointestinal (GI) symptoms was assessed among patients using medical marijuana (MMJ). METHODS: Participants completed surveys at 0 days, 30 days, 6 months, and 12 months with questions about the …
observational
2022
INTRODUCTION: Medicinal cannabis is prescribed in Australia for patients with chronic refractory pain conditions. However, measures of safety and effectiveness of different cannabinoids are lacking. We designed an observational study to cap…
2020
2019
review
2019
The endocannabinoid system (ECS) is a multifunctional homeostatic system involved in many physiological and pathological conditions. The ligands of the ECS are the endo-cannabinoids, whose actions are mimicked by exogenous cannabinoids, suc…